Drug General Information (ID: DDIPUIR12S)
  Drug Name Bleomycin Drug Info Cisplatin Drug Info
  Drug Type Small molecule Small molecule
  Therapeutic Class Antineoplastics Antineoplastics
  Structure

 Mechanism of Bleomycin-Cisplatin Interaction (Severity Level: Moderate)
     Increased risk of nephrotoxicity Click to Show/Hide Mechanism Graph
Could Not Find 2D Structure
      Drug Name Bleomycin Cisplatin
      Mechanism Nephrotoxicity Nephrotoxicity
      Key Mechanism Factor 1
Factor Name Nephrotoxicity
Factor Description The combination of drugs that can induce nephrotoxicity may increase the risk of kidney injury. When kidney injury occurs, the inability to remove excess urine and waste from the body can lead to high levels of urea nitrogen, creatinine, and electrolytes (such as potassium and magnesium) in the blood.
      Mechanism Description
  • Increased risk of nephrotoxicity by the combination of Bleomycin and Cisplatin 

Recommended Action
      Management Close clinical and laboratory monitoring of renal and neurologic function and drug serum concentrations (if clinically appropriate) is recommended.

References
1 Cerner Multum, Inc. "Australian Product Information.".
2 Cerner Multum, Inc. "UK Summary of Product Characteristics.".